| scholarly article | Q13442814 |
| P2093 | author name string | Romain A Colas | |
| Jesmond Dalli | |||
| Mary E Walker | |||
| Patricia R Souza | |||
| P2860 | cites work | Quantitative analysis of monocyte subpopulations in murine atherosclerotic plaques by multiphoton microscopy | Q27319442 |
| Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis | Q27334082 | ||
| Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections | Q28265796 | ||
| Different modes of pathogenesis in T-cell-dependent autoimmunity: clues from two TCR transgenic systems | Q33713313 | ||
| Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue | Q33840123 | ||
| Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation | Q34218574 | ||
| Statin therapy for primary prevention of cardiovascular disease | Q34387879 | ||
| Pathways involved in the resolution of inflammatory joint disease | Q34475132 | ||
| Cell-cell interactions and bronchoconstrictor eicosanoid reduction with inhaled carbon monoxide and resolvin D1. | Q34519343 | ||
| Human neutrophils in auto-immunity | Q34520590 | ||
| Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins | Q34522097 | ||
| Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin | Q34787395 | ||
| Lovastatin decreases acute mucosal inflammation via 15-epi-lipoxin A4. | Q35679301 | ||
| Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation | Q36236176 | ||
| Targeting the stromal microenvironment in chronic inflammation. | Q36472008 | ||
| The role of simvastatin in the therapeutic approach of rheumatoid arthritis | Q36959612 | ||
| Effect of Atorvastatin on the Disease Activity and Severity of Rheumatoid Arthritis: Double-Blind Randomized Controlled Trial | Q37102751 | ||
| An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques | Q37282266 | ||
| Evaluation of the Anti-inflammatory Effects of Atorvastatin on Patients with Rheumatoid Arthritis: A Randomized Clinical Trial | Q37316891 | ||
| Synthesis of 13(R)-Hydroxy-7Z,10Z,13R,14E,16Z,19Z Docosapentaenoic Acid (13R-HDPA) and Its Biosynthetic Conversion to the 13-Series Resolvins | Q37491685 | ||
| Accelerated resolution of inflammation underlies sex differences in inflammatory responses in humans. | Q37545061 | ||
| Modulation of Neutrophil Apoptosis and the Resolution of Inflammation through β2 Integrins | Q38091028 | ||
| Do statins reduce the cardiovascular risk in patients with rheumatoid arthritis? | Q38220433 | ||
| Cardiovascular disease in rheumatoid arthritis: Current perspectives on assessing and mitigating risk in clinical practice | Q38677228 | ||
| Resolution of inflammation: a new therapeutic frontier | Q38791244 | ||
| Immune resolution mechanisms in inflammatory arthritis | Q39067604 | ||
| The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis | Q39078542 | ||
| Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms | Q39088075 | ||
| Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias | Q41454232 | ||
| Prevalence of dyslipidemia in Japanese patients with rheumatoid arthritis and effects of atorvastatin treatment | Q41466368 | ||
| Methods for assessing the effects of galectins on leukocyte trafficking | Q41727318 | ||
| Nonclassical Ly6C(-) monocytes drive the development of inflammatory arthritis in mice. | Q42984890 | ||
| Changes in disease activity, cytokine production, and proliferation of peripheral blood mononuclear cells in patients with rheumatoid arthritis after simvastatin treatment | Q46335265 | ||
| Bone protective effect of simvastatin in experimental arthritis | Q46606409 | ||
| Leukocyte engagement of platelet glycoprotein Ibalpha via the integrin Mac-1 is critical for the biological response to vascular injury | Q46783981 | ||
| Resolving Lipid Mediators Maresin 1 and Resolvin D2 Prevent Atheroprogression in Mice | Q49112867 | ||
| Monocyte-platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation. | Q55059334 | ||
| Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat | Q80111741 | ||
| Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis | Q80843926 | ||
| Pharmacological control of platelet-leukocyte interactions by the human anti-P-selectin antibody inclacumab--preclinical and clinical studies | Q86476800 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3636-3648 | |
| P577 | publication date | 2017-05-02 | |
| P1433 | published in | FASEB Journal | Q520194 |
| P1476 | title | 13-Series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis | |
| P478 | volume | 31 |
| Q51747428 | A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults. |
| Q64120892 | Can Inflammation-Resolution Provide Clues to Treat Patients According to Their Plaque Phenotype? |
| Q91633418 | GPR101 mediates the pro-resolving actions of RvD5n-3 DPA in arthritis and infections |
| Q64898835 | Identification and structure elucidation of the pro-resolving mediators provides novel leads for resolution pharmacology. |
| Q90341460 | Novel n-3 Docosapentaneoic Acid-Derived Pro-resolving Mediators Are Vasculoprotective and Mediate the Actions of Statins in Controlling Inflammation |
| Q55216618 | RvT1-4 translocate from cytosol to extracellular region |
| Q49585219 | Stereocontrolled synthesis and investigation of the biosynthetic transformations of 16(S),17(S)-epoxy-PDn-3 DPA. |
Search more.